| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |